GSK to pull its OTC codeine

GSK has announced that it will pull its codeine-containing OTCs, as the Guild talks accessibility with the TGA GSK issued a statement advising that it will not move its S3 codeine range to prescription only next year. "We (GSK) respect the delegate’s decision to upschedule codeine-containing analgesic from 1st February, 2018, which was based on